Sakagami H, Takeda M, Utsumi A, Fujinaga S, Tsunoda A, Yasuda N, Shibusawa M, Koike T, Ota H, Kazama K
First Department of Biochemistry, School of Medicine, Showa University, Tokyo, Japan.
Anticancer Res. 1993 Jan-Feb;13(1):65-71.
Intravenous administration of sodium benzylideneascorbate (SBA) dose-dependently induced degeneration (vacuolar and eosinophilic degeneration and cell shrinkage and nuclear condensation, which are characteristic of apoptotic cell death) of 3'-methyl-4-dimethylaminoazobenzene-induced rat hepatocellular carcinoma. SBA did not significantly induce lymphocyte infiltration and fibrosis in the liver, nor damage the gross morphology of kidney and spleen cells. SBA failed to stimulate the production of tumor necrosis factor and interleukin-1 beta in both in vitro and in vivo systems. These results may suggest a direct antitumor action of SBA via induction of apoptosis in the tumor. However, SBA did not significantly affect the doubling time, or the extent of invasion and differentiation of dimethylhydrazine-induced colon carcinoma in rats. These data suggest that the conditions of SBA administration should be re-established for each tumor sample to produce maximum antitumor activity.
静脉注射亚苄基抗坏血酸钠(SBA)可剂量依赖性地诱导3'-甲基-4-二甲基氨基偶氮苯诱导的大鼠肝细胞癌发生变性(空泡化和嗜酸性变性以及细胞皱缩和核浓缩,这些是凋亡性细胞死亡的特征)。SBA并未显著诱导肝脏中的淋巴细胞浸润和纤维化,也未损害肾脏和脾脏细胞的大体形态。在体外和体内系统中,SBA均未能刺激肿瘤坏死因子和白细胞介素-1β的产生。这些结果可能表明SBA通过诱导肿瘤细胞凋亡发挥直接抗肿瘤作用。然而,SBA对大鼠二甲基肼诱导的结肠癌的倍增时间、侵袭程度和分化程度没有显著影响。这些数据表明,对于每个肿瘤样本,应重新确定SBA的给药条件以产生最大的抗肿瘤活性。